Drug regulation reform--oversight. hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session, on food and drug administration regulation of research, development, and marketing of drugs, June 25, 1980.

Drug regulation reform--oversight. hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session, on food and drug administration regulation of research, development, and marketing of drugs, June 25, 1980. Volume 1, New drug approval process :

Saved in:

Bibliographic Details
Corporate Author:	United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Health and the Environment (Author)
Format:	Online
Language:	English
Published:	Washington : U.S. Government Printing Office, 1980.
Series:	U.S. Congressional documents. Congressional hearings.
Subjects:	United States. > Food and Drug Administration. Drugs > Law and legislation > United States. Pharmacy > Law and legislation > United States. Drug approval > United States. Electronic books.
Online Access:	HeinOnline U.S. Congressional Documents Collection
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Drug regulation reform--oversight : hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress ..
Published: (1980)

Drug regulation reform--oversight. hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress on how can we best use our limited resources and at the same time insure safe and effective drugs to diseases which occur infrequently.
Published: (1980)

How FDA approves drugs and regulates their safety and effectiveness /
by: Thaul, Susan
Published: (2012)

How FDA approves drugs and regulates their safety and effectiveness /
by: Bodie, Agata, et al.
Published: (2018)

How FDA approves drugs and regulates their safety and effectiveness /
by: Thaul, Susan
Published: (2012)

How FDA approves drugs and regulates their safety and effectiveness.
Published: (2013)

The regulation of new drugs by the Food and Drug Administration : the new drug review process : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-seventh Congress, second session, August 3 and 4, 1982.
Published: (1982)

The regulation of new drugs by the Food and Drug Administration : the new drug review process : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-seventh Congress, second session, August 3 and 4, 1982
Published: (1982)

European Union: authorization of drugs already approved in the United States /
by: Papademetriou, Theresa
Published: (2015)

FDA's authority to regulate drug compounding : a legal analysis /
by: Staman, Jennifer A.
Published: (2012)

Drug safety amendments of 1976 : hearings before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fourth Congress, second session, on H.R. 11617 and H.R. 12391, bills to amend the Federal food, drug, and cosmetic act, March 29 and 30, April 1, 1976, and H.R. 14289, a bill to amend the federal food, drug, and cosmetic act and related provisions of law to improve the protection of the public health and safety with respect to drugs, June 22, 23, and 24, 1976.
Published: (1976)

Access to unapproved drugs : FDA policies on compassionate use and emergency use authorization.
Published: (2015)

The pharmaceutical drug development process /
by: Bodie, Agata, et al.
Published: (2019)

Oversight of the new drug review process and FDA's regulation of Merital : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-ninth Congress, second session, May 22, 1986.
Published: (1987)

Oversight of the new drug review process and FDA's regulation of Merital : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-ninth Congress, second session, May 22, 1986
Published: (1987)

Commission on the Federal Drug Approval Process : final report /
Published: (1982)

Drug shortages : causes, FDA authority, and policy options /
by: Bodie, Agata
Published: (2018)

The regulation of pharmaceuticals : balancing the benefits and risks /
by: Grabowski, Henry G
Published: (1983)

Drug Regulation Reform Act of 1979 : hearings before the Subcommittee on Health and Scientific Research of the Committee on Labor and Human Resources, United States Senate, Ninety-sixth Congress, first session on S. 1075, to revise and reform federal law applicable to drugs for human use, and for other purposes and related bills, May 17 and 18, 1979.
Published: (1979)

Drug regulation reform act of 1978 : hearings before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session, on H.R. 11611 (and all other similar and identical bills)
Published: (1978)

FDA's generic drug approval process. hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1989)

FDA's generic drug approval process. hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1990)

FDA's generic drug approval process. hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1991)

Generic drug enforcement : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session on H.R. 2454, a bill to authorize the Secretary of Health and Human Services to impose debarments and other penalties for illegal activities involving the approval of abbreviated drug applications under the Federal Food, Drug, and Cosmetic Act, June 26, 1991.
Published: (1991)

Drug regulation reform act of 1979 : hearings before the Subcommittee on Health and Scientific Research of the Committee on Labor and Human Resources, United States Senate, Ninety-sixth Congress, first session, on S. 1075 ... May 17 and 18, 1979
Published: (1979)

Drug regulation reform act of 1978 : hearings before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, United States Senate, Ninety-fifth Congress, second session on S. 2755
Published: (1978)

Improving animal health : reauthorization of FDA animal drug user fees : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session on examining improving animal health, focusing on reauthorization of Food and Drug Administration animal drug user fees, February 13, 2018.
Published: (2020)

Drug Regulation Reform Act of 1978. hearings before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session on H.R. 11611 (and all other similar and identical bills), bills to revise and reform the federal law applicable to drugs for human use and to establish a National Center for Clinical Pharmacology within the Department of Health, Education, and Welfare, and for other purposes, June 6, 12, 13, 14, 15, 19, 20, 21, 22, 23, and 27, 1978.
Published: (1979)

Drug Regulation Reform Act of 1978. hearings before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session on H.R. 11611 (and all other similar and identical bills), bills to revise and reform the federal law applicable to drugs for human use and to establish a National Center for Clinical Pharmacology within the Department of Health, Education, and Welfare, and for other purposes, June 6, 12, 13, 14, 15, 19, 20, 21, 22, 23, and 27, 1978.
Published: (1978)

Drug Regulation Reform Act of 1978 : hearings before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, United States Senate, Ninety-fifth Congress, second session on S. 2755, to revise and reform the federal law applicable to drugs for human use and to establish a National Center for Clinical Pharmacology within the Department of Health, Education, and Welfare, March 17; April 11, 12; and May 17, 1978, Washington, D.C., May 18, 1978, Rockville, Md.
Published: (1978)

Pre-ANDA litigation : strategies and tactics for developing a drug product and patent portfolio /
Published: (2014)

The law of drugs and druggists : a treatise with text, cases, statutes, readings, and digests for schools of pharmacy, retail, wholesale, and manufacturing druggists /
by: Arthur, William Reed, 1876-
Published: (1947)

Preclinical and clinical testing by the pharmaceutical industry, 1978. hearing before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, United States Senate, Ninety-fifth Congress, second session on examination of the process of drug testing and FDA' role in the regulation and conditions under which such testing is carried out, March 7, 1978.
Published: (1978)

Preclinical and clinical testing by the pharmaceutical industry, 1977. hearing before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, United States Senate, Ninety-fifth Congress, first session on examination of the process of drug testing and FDA' role in the regulation and conditions under which such testing is carried out, March 10, 1977.
Published: (1977)

Animal drug user fee agreements : advancing animal health for the public : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, first session on examining animal drug user fee agreements, focusing on advancing animal health for the public health, February 27, 2013.
Published: (2014)

Emergency use authorization and FDA's related authorities /
by: Bodie, Agata
Published: (2018)

Colloquy on the Drug Approval Process /
Published: (1989)

The regulation of pharmaceuticals : balancing the benefits and risks /
by: Grabowski, Henry G., et al.
Published: (1983)

Rare diseases : expediting treatments for patients : hearing before the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session on examining rare diseases, focusing on expediting treatments for patients, October 3, 2018.
Published: (2020)

Food, Drug, and Cosmetic Act Amendments of 1977 : hearings before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, United States Senate, Ninety-fifth Congress, first session on S. 1831, to amend the Public Health Services Act to provide for a national center for clinical pharmacology, to provide support for the study of clinical pharmacology and clinical pharmacy, and to provide for review of, drug prescribing; and to amend the Federal Food, Drug, and Cosmetic Act, as amended, to provide for the continuation and expansion of existing authority through the establishment of an appropriate mechanism to be known as the Federal Food, Drug, Cosmetic, and Devices Administration; to provide for additional regulation of the pharmaceutical industry, and for other purposes and related bills, July 26 and 27, 1977.
Published: (1978)